Cite
Shinoda M, Ebinuma H, Itano O, et al. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016;46(11):1118-1128doi: 10.1111/hepr.12666.
Shinoda, M., Ebinuma, H., Itano, O., Yamagishi, Y., Obara, H., Kitago, M., Nakamoto, N., Hibi, T., Yagi, H., Abe, Y., Matsubara, K., Chu, P. S., Wakayama, Y., Taniki, N., Yamaguchi, A., Amemiya, R., Miyake, R., Mizota, T., Kanai, T., & Kitagawa, Y. (2016). Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatology research : the official journal of the Japan Society of Hepatology, 46(11), 1118-1128. https://doi.org/10.1111/hepr.12666
Shinoda, Masahiro, et al. "Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,11 (2016): 1118-1128. doi: https://doi.org/10.1111/hepr.12666
Shinoda M, Ebinuma H, Itano O, Yamagishi Y, Obara H, Kitago M, Nakamoto N, Hibi T, Yagi H, Abe Y, Matsubara K, Chu PS, Wakayama Y, Taniki N, Yamaguchi A, Amemiya R, Miyake R, Mizota T, Kanai T, Kitagawa Y. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatol Res. 2016 Oct;46(11):1118-1128. doi: 10.1111/hepr.12666. Epub 2016 Apr 22. PMID: 26854748.
Copy
Download .nbib